Alpha-bungarotoxin Binding to Acetylcholine Receptor Membranes Studied by Low Angle X-ray Diffraction
Overview
Authors
Affiliations
The nicotinic acetylcholine receptor (nAChR) carries two binding sites for snake venom neurotoxins. alpha-Bungarotoxin from the Southeast Asian banded krait, Bungarus multicinctus, is a long neurotoxin which competitively blocks the nAChR at the acetylcholine binding sites in a relatively irreversible manner. Low angle x-ray diffraction was used to generate electron density profile structures at 14-A resolution for Torpedo californica nAChR membranes in the absence and presence of alpha-bungarotoxin. Analysis of the lamellar diffraction data indicated a 452-A lattice spacing between stacked nAChR membrane pairs. In the presence of alpha-bungarotoxin, the quality of the diffraction data and the lamellar lattice spacing were unchanged. In the plane of the membrane, the nAChRs packed together with a nearest neighbor distance of 80 A, and this distance increased to 85 A in the presence of toxin. Electron density profile structures were calculated in the absence and presence of alpha-bungarotoxin, revealing a location for the toxin binding sites. In native, fully-hydrated nAChR membranes, alpha-bungarotoxin binds to the nAChR outer vestibule and contacts the surface of the membrane bilayer.
Rashmi U, Bhatia S, Nayak M, Khochare S, Sunagar K Front Pharmacol. 2024; 15:1443073.
PMID: 39575383 PMC: 11579489. DOI: 10.3389/fphar.2024.1443073.
Zhang Y, Dos Santos M, Huang H, Chen K, Iyengar P, Infante R Cell Rep. 2024; 43(8):114587.
PMID: 39116208 PMC: 11472345. DOI: 10.1016/j.celrep.2024.114587.
Bahauddin A, Curtis K, Guptarak J, Huda R Antibodies (Basel). 2024; 13(3).
PMID: 39051329 PMC: 11270186. DOI: 10.3390/antib13030053.
Lipid Membrane State Change by Catalytic Protonation and the Implications for Synaptic Transmission.
Fillafer C, Koll Y, Schneider M Membranes (Basel). 2022; 12(1).
PMID: 35054529 PMC: 8781637. DOI: 10.3390/membranes12010005.
Shestakova K, Mesonzhnik N, Markin P, Moskaleva N, Nedorubov A, Brito A Pharmaceuticals (Basel). 2021; 14(7).
PMID: 34358094 PMC: 8308683. DOI: 10.3390/ph14070668.